glucose like peptideglucose like peptide GLP-1 enhances glucose-induced insulin secretion - Glucagonlike peptide1 中文 Glucagon-like peptide-1 receptor agonists Understanding Glucagon-Like Peptide-1 (GLP-1) and Its Role in Glucose Metabolism

Glucagonlike peptide1 中文 Glucagon-like peptide-1 (GLP-1) is a crucial peptide hormone that plays a significant role in regulating glucose homeostasis.作者：MA Luque·2002·被引用次数：181—Glucagon-like peptide-1 (GLP-1) has been shown to have insulin-like effects upon the metabolism of glucose in rat liver, muscle and fat, and on that of ... As an incretin hormone, GLP-1 is primarily secreted by enteroendocrine L cells located in the small and large intestine in response to nutrient intakeSeparate and Combined Glucometabolic Effects of .... Its discovery and subsequent research have shed light on its multifaceted physiological functions, particularly in the context of diabetes and metabolic health.作者：E Bahne·2018·被引用次数：182—GLP-1 enhances glucose-induced insulin secretionand inhibits glucagon secretion. Moreover, GLP-1 delays gastric emptying and reduces appetite ...

The Physiological Actions of GLP-1

GLP-1 is a 30- or 31-amino-acid-long peptide hormone derived from the proglucagon precursor. Its secretion is nutrient-dependent, meaning it is released after meals, signaling to the body that glucose is available. Once released, GLP-1 exerts several beneficial effects on glucose metabolismGlucagon-like peptide-1 (GLP-1) and glucose metabolism ....

One of its primary actions is to stimulate glucose-dependent insulin secretion from pancreatic beta cells. This means that GLP-1 enhances the release of insulin only when blood glucose levels are elevated, thereby preventing hypoglycemia作者：R MENTLEIN·1993·被引用次数：1569—Peptidesof the glucagon/vasoactive-intestinal-peptide(VIP)peptidefamily share a considerable sequence similarity at their N-terminus.. Concurrently, GLP-1 lowers blood glucose by inhibiting glucagon secretion from pancreatic alpha cells. Glucagon is a hormone that raises blood glucose levels, so its suppression is beneficial for maintaining stable blood sugar.

Beyond its direct effects on insulin and glucagon, GLP-1 also influences glucose metabolism through other mechanisms. It delays gastric emptying, which slows down the absorption of nutrients from the digestive tract and contributes to a more gradual rise in blood glucose after a meal.Abstract.Glucagon-like peptide-1 (GLP-1) is the most potent endogenous insulin-stimulating hormone. In the present study the plasma stability and ... Furthermore, GLP-1 has been shown to reduce appetite and promote satiety, which can lead to decreased food intake and potentially aid in weight management.

GLP-1 and Its Therapeutic Applications

The profound effects of GLP-1 on glucose metabolism have made it a prime target for therapeutic interventions, particularly for type 2 diabetes and obesity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of medications that mimic the action of endogenous GLP-1. These drugs have gained significant traction in recent years for their efficacy in managing these conditions.

GLP-1 is closely related to another incretin hormone, glucose-dependent insulinotropic polypeptide (GIP). Both play roles in postprandial glucose regulationThe C-peptide/Glucose Ratio (CGR). While natural GLP-1 has a short half-life in the body due to rapid degradation by the enzyme dipeptidyl-peptidase IV (DPP-IV), GLP-1RAs are designed to be more resistant to this breakdown, providing a more sustained effect.

The therapeutic potential of GLP-1 is extensive.2019年1月9日—The incretin hormonesglucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are secreted postprandially and ... Research has indicated that GLP-1 can inhibit cell apoptosis and improve the glucose responsiveness of freshly isolated human islets. This suggests a role in preserving pancreatic beta-cell function. Moreover, studies have explored the impact of various peptides and their analogs on glucose and insulin sensitivity.

Beyond GLP-1: Related Concepts in Glucose Monitoring

While GLP-1 is a key player in glucose regulation, other markers are used to assess pancreatic function and glucose metabolism. The C-peptide test, for instance, measures C-peptide in your blood or urine. C-peptide is a byproduct of insulin production, and measuring its levels can help determine how much insulin the pancreas is producing.Glucagon-like peptide 1 (GLP-1) - PMC This is particularly useful in distinguishing between type 1 and type 2 diabetes and guiding treatment decisions. The Peptide/Glucose ratio, such as the C-peptide/Glucose ratio, can offer further insights into insulin secretory capacity作者：B Jones·2015—Glucagon-like peptide 1inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. ... Determinants of the impaired secretion ....

The Significance of GLP-1 in Diabetes and Obesity

The glucagon-like peptide-1 (GLP-1) system is a vital component of the body's intricate mechanisms for regulating blood glucose. Its ability to enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite makes it a compelling therapeutic target for conditions characterized by impaired glucose metabolism and excess weight. As research continues, our understanding of glucagon-like peptides (GLPs), including GLP-1 and GLP-2, and their broader impact on health is expanding, solidifying their importance in metabolic medicine.